A paradigm shift in drug delivery systems
TissueGen's proprietary technology makes possible extended release formulations for drugs ranging from small molecules to temperature-sensitive biologics. Our patent-protected technology is particularly well suited to creating a new class of drug-eluting devices designed to orchestrate the body's own healing processes to significantly improve clinical outcomes after trauma or surgery.
ABOUT
biologics. Our patent-protected technology is particularly well suited to creating a new class
release formulations for drugs ranging from small molecules to temperature-sensitive
TissueGen's proprietary technology makes possible extended
of drug-eluting devices designed to orchestrate the body's own healing processes
to significantly improve clinical outcomes after trauma or surgery.
- Dr. Kevin Nelson, Founder and CSO
APPLICATIONS
Â
Â
/ 0 3
/ 0 3
/ 0 3